التفاصيل البيبلوغرافية
| العنوان: |
Hepatoprotective activity of Tamarindus indica Linn stem bark ethanolic extract against hepatic damage induced by co-administration of antitubercular drugs isoniazid and rifampicin in Sprague Dawley rats. |
| المؤلفون: |
Meena, Shaikh Zohra, Rahman, Md. Azizur, Bagga, Paramdeep, Mujahid, Md. |
| المصدر: |
Journal of Basic & Clinical Physiology & Pharmacology; Jan2019, Vol. 30 Issue 1, p131-137, 7p |
| مصطلحات موضوعية: |
ALKALINE phosphatase, ANIMAL experimentation, ASPARTATE aminotransferase, BARK, BILIRUBIN, BIOMARKERS, BODY weight, CELLULOSE, COMBINATION drug therapy, CHOLESTEROL, ETHANOL, FLAVONOIDS, HISTOLOGICAL techniques, ISONIAZID, LACTATE dehydrogenase, LIVER, LIVER diseases, ORAL drug administration, PEPTIDES, RATS, RIFAMPIN, PLANT stems, PLANT extracts, ALBUMINS, ALANINE aminotransferase |
| مستخلص: |
Background: Development of drug-induced hepatic damage (DIHD) during chemotherapy is the most common reason for interruption in chemotherapy. This study evaluated the hepatoprotective activity of the ethanolic extract of Tamarindus indica stem bark (EETI) against the induced DIHD in Sprague Dawley rats. Methods: The rats were divided into five groups (n=5). Group I, group III, group IV, and group V rats received 1 mL 1% carboxymethyl cellulose, EETI 100 mg/kg body weight (b.wt), EETI 200 mg/kg b.wt, and silymarin 100 mg/kg b.wt, respectively, orally once every day for 28 days. After 1 h–group II, group III, group IV, and group V rats were administered with isoniazid (INH) and rifampicin (RIF) 50 mg/kg b.wt each orally once every day for 28 days. Then, 24 h after the last dosing, blood was withdrawn from the rats and analyzed for liver specific enzymes and biochemical markers. They were examined for histopathology. Results: Co-administration of INH and RIF in group II significantly increased alanine transaminase, aspartate transaminase, alkaline phosphatase, lactate dehydrogenase, serum bilirubin, and cholesterol levels while reduced the total protein and albumin levels compared to that of group I. EETI in group III and group IV rats significantly restored the liver specific enzymes and biochemical markers altered due to co-administration of INH and RIF to normal in a dose-dependent manner. EETI 200 mg/kg b.wt showed better protection to liver than EETI 100 mg/kg b.wt and was comparable to silymarin 100 mg/kg b.wt. It was well supported with histopathology of liver tissues. Conclusions: EETI possesses hepatoprotective activity against DIHD in rats. It may have a substantial impact on developing clinical strategies to treat patients with hepatic damage. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Basic & Clinical Physiology & Pharmacology is the property of De Gruyter and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Supplemental Index |
